FDA approves Glenmark's OTC acetaminophen and ibuprofen tablets
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA.
Glenmark has received permission from the Food and Drug Administration for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), which is the bioequivalent of Haleon’s Advil Dual Action with Acetaminophen Tablets.
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the United States by Glenmark Therapeutics, USA.
[Read more: Glenmark expands OTC portfolio with acquisition of Wockhardt’s ANDAs]
Advil Dual Action with Acetaminophen Tablets, 250 mg/125 mg (OTC) had a market value of approximately $84.1 million, per Nielsen syndicated data for the latest 52 weeks ending March 23, 2024.